Litigation Details for Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)
✉ Email this page to a colleague
Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-09-15 |
Court | United States Bankruptcy Court, S.D. New York | Date Terminated | |
Cause | Assigned To | Sean H. Lane | |
Jury Demand | Referred To | ||
Parties | BAYARD, P.A.; KROLL RESTRUCTURING ADMINISTRATION LLC; KROLL RESTRUCTURING ADMINISTRATION LLC CLAIMS AGENT; PURDUE PHARMA L.P.; UNITED STATES TRUSTEE | ||
Patents | 10,004,819; 10,006,091; 10,011,659; 10,011,857; 10,017,712; 10,058,630; 10,114,022; 10,125,364; 10,300,010; 10,407,434; 6,004,968; 6,398,671; 7,005,420; 7,048,928; 7,423,050; 7,658,945; 7,777,050; 7,897,050; 7,982,078; 8,003,762; 8,007,830; 8,008,003; 8,008,006; 8,017,074; 8,080,575; 8,134,000; 8,269,040; 8,313,778; 8,337,888; 8,653,033; 8,722,684; 9,023,001; 9,023,391; 9,060,976; 9,073,933; 9,090,815; 9,090,945; 9,193,757; 9,522,919; 9,555,000; 9,700,050; 9,730,934 | ||
Attorneys | Chane Buck; Darren S. Klein; Dennis Windscheffel; George W. Shuster, Jr.; Jeffrey R. Gleit; Nathan Yeary; Van C. Durrer, II | ||
Firms | Akin Gump Strauss Hauer & Feld, LLP; Akin Gump Strauss Hauer and Feld; Dennis Windscheffel; Office of the United States Trustee; Skadden, Arps, Slate, Meagher & Flom LLP; Sullivan and Worcester LLP; Wilmer, Cutler, Pickering, Hale & Dorr, LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Purdue Pharma L.P.
Biologic Drugs cited in Purdue Pharma L.P.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Purdue Pharma L.P. (Bankr. S.D.N.Y. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-05-30 | 1195 | Monthly Fee Statement | .7). $5,420.00…Hourly Rates for Patent Services [Docket No. 965] (the “Notice of Increased Patent Fees”). …10% for patent agents. 6 As described in the Notice of Increased Patent Fees,…Hourly Rates for Patent Services [Docket No. 965] (the “Notice of Increased Patent Fees”). 19-23649… U.S. Patent and Trademark Office Electronic Patent Assignments | External link to document |
2020-06-03 | 1220 | Monthly Fee Statement | $1,080 4.6 $4,968.00 2017; admitted…regarding patent assignments. Chen, Bonnie 04/03/20 2.5 Revise patent assignments…regarding patent assignments (0.5); revise patent assignments… patent assignments (0.3); review patents for documentary due … deck slides related to patent assignments (0.2); revise patent | External link to document |
2020-07-14 | 1382 | Monthly Fee Statement | Litigation 2017 $650.00 14.70 $9,555.00 Anthony Hilbert Corporate 2019… 14.70 at $650.00 = $9,555.00 R BAYEFSKY 12.90 … to patent licenses; research re statements in 4.40 patents (2.6…revise assessment of patents (1.2). 05/20/20 DCV 0032 Analyze patent license agreements and….30 05/01/20 DCV 0032 Review Purdue patents and file histories (1.6); update analysis re same | External link to document |
2020-07-15 | 1407 | Application for Interim Professional Compensation | 1979 $1,240.00 101.10 $125,364.00 Stephen Kho International …Litigation 1979 $1,240.00 101.10 $125,364.00 Stephen Kho International …in connection with analyzing the Debtors’ patents and patent applications, intellectual property license…related to patent history, prosecution, and expiration; product exclusivity and expiration of patent coverage… ongoing, former and potential patent litigation (in particular patent infringement litigation), and | External link to document |
2020-07-17 | 1441 | Application for Interim Professional Compensation | 1979 $1,240.00 101.10 $125,364.00 Stephen Kho International …Litigation 1979 $1,240.00 101.10 $125,364.00 Stephen Kho International …in connection with analyzing the Debtors’ patents and patent applications, intellectual property license…related to patent history, prosecution, and expiration; product exclusivity and expiration of patent coverage… ongoing, former and potential patent litigation (in particular patent infringement litigation), and | External link to document |
2020-07-20 | 1463 | Response to Motion | ,412, as U.S. Patent Nos. 8,337,888 (the “’888 patent”); 9,060,976 (the “’976 patent”); and 9,034,376…certain of the Debtors’ patents, including U.S. Patent No. 9,693,961 (“the ’961 Patent”). Shortly after the… Patent 9,693,961 B2 A. Related Proceedings Patent Owner asserted the ’961 patent against…Response, Patent Owner contends that, “transitional” continuation patents such as the ’961 patent are not…before the Patent Trial and Appeal Board (the “PTAB”), seeking a determination that the ’961 patent was invalid | External link to document |
2020-08-19 | 1592 | Objection to Motion | other patents in suit – U.S. Patent Nos. 9,073,933 (“’933 Patent”) and 9,522,919 (“’919 Patent”). These…of one of the Debtors’ patents, U.S. Patent No. 9,693,961 B2 (the “’961 Patent”). Collegium’s Response…’961 Patent — the subject of the PTAB Action — is just one of the patents in suit in the Patent Litigation…Action”) before the United States Patent and Trademark Office’s Patent Trial and Appeal Board (the “PTAB…These patents are not related to the ’961 Patent — they have different specifications, different records | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |